9 research outputs found

    Séries temporelles: déterminants pathologiques des examens cytobiochimiques d´urines et infection urinaire entre 2011-2014 aux cliniques universitaires de Kinshasa

    Get PDF
    Introduction: l´examen cytobiochimique urinaire est un outil complĂ©mentaire le plus demandĂ© au laboratoire Ă  cĂ´tĂ© de l´hĂ©mogramme. Il a une grande valeur prĂ©dictive dans les infections urinaires quand il est correctement fait et scrupuleusement interprĂ©tĂ©. L´objectif de cette Ă©tude Ă©tait d´évaluer l´ampleur, l´évolution, les dĂ©terminants, et les comorbiditĂ©s cytobiochimiques de l´infection urinaire. MĂ©thodes: il s´est agi d´une Ă©tude documentaire, avec des approches, descriptive, analytique et comparative portant sur des patients rĂ©fĂ©rĂ©s pour examens cytobiochimiques des urines aux laboratoires de Cliniques Universitaires de Kinshasa (CUK) entre 2011 et 2014. RĂ©sultats: au total, 8926 analyses cytobiochimiques ont Ă©tĂ© demandĂ©es avec moins de 2% d´analyses biochimiques. Les femmes Ă©taient plus reprĂ©sentĂ©es (6426 femmes vs 2500 hommes) avec un sex ratio 3F:1H. Il y avait plus de demandes dans la tranche d´âge de 30-39 ans (17%; n=1517). Les analyses ont plus Ă©tĂ© demandĂ©es pendant les saisons de pluies 72% (n=3511) avec le pic pendant les mois de mai. Les infections urinaires estimĂ©es Ă  54,8% [n=4892 ajustĂ© dont E. coli (n=1937), Klebsiella (n= 993)] Ă©taient plus diagnostiquĂ©s pendant la pĂ©riode de 2012 Ă  2014. Il existait une association indĂ©pendante et significative entre le sexe fĂ©minin (OR aj = 3,5; IC = 95%; 3,1-3,8; P<0,0001, l´admission pendant les saisons de pluies (OR aj = 1,3, IC = 95%; 1,2-1,4; P<0,0001 et l´infection urinaire. Conclusion: l´infection urinaire Ă©merge comme une prĂ©occupation majeure pour les patients de sexe fĂ©minin et admises pendant les saisons de pluies et les annĂ©es 2012-2014 de la sĂ©rie de 2011 Ă  2014 aux CUK. La raretĂ© de l´infection urinaire Ă©tait observĂ©e au cours de l´annĂ©e La Nina 2011 post-l´annĂ©e trop chaude EL Nino alors que l´ampleur de l´infection urinaire Ă©tait coexistante pendant les annĂ©es 2012-2014 normales relativement chaudes prĂ©-l´annĂ©e très chaude El Nino 2015. Il existe donc une interaction entre le climat tropical chaud et humide de la ville de Kinshasa et le climat global (mondial) froid dans le cadre de la variabilitĂ© climatique/rĂ©chauffement climatique, pouvant expliquer la flambĂ©e des infections urinaire Ă  Kinshasa

    Etude observationnelle sur l’hémovigilance transfusionnelle à Kinshasa, République Démocratique du Congo: Haemovigilance in blood transfusion: an observational study from Kinshasa, the Democratic Republic of the Congo

    Get PDF
    Context and objective. Although most countries in sub-Saharan Africa have transfusion centers, haemovigilance data are paradoxically scarce. The objective of the present study was to identify the recipient adverse effect (RAT) of blood transfusion. Methods. We conducted a cross-sectional observational study in two blood transfusion centers in Kinshasa, between July and November 2015. The general principles of haemovigilance during the transfusion episode were observed to identify the EIR. On each blood product, bacteriological, immunological, serological and parasitic analyzes were systematically performed. Results. 346 subjects were enrolled (female, 53.2%).The overall frequency of RAT during transfusion was 2.9%. It was most commonly urticaria (5 cases), pruritus (4 cases), fever (3 cases) and vomiting (3 cases). Control tests on patients with RAT yielded the following results: 2 seropositive for Human Immunodeficiency Virus (HIV), 2 seropositive for Hepatitis C virus (HVC), and 1 seropositive for Rapid Plasma Reagent (RPR) test. Conclusion. RAT is relatively common in Kinshasa due partially to compatibility error. The observance of the protocols of haemovigilance system is not optimal in both hospitals studied. A large multicenter study should be performed to better identify the concerns and thus secure blood products. Contexte et objectif. Bien que la plupart de pays d’Afrique subsaharienne aient de centres transfusionnels, mais les données sur l’hémovigilance sont paradoxalement fragmentaires. L’objectif de la présente étude était d’identifier l’effet indésirable du receveur (EIR) transfusionnel. Méthodes. Nous avons réalisé une étude observationnelle transversale dans deux centres de transfusion sanguine à Kinshasa, entre juillet et novembre 2015.Les principes généraux de l’hémovigilance au cours de l’épisode transfusionnel ont été observés en vue d’identifier l’EIR. Pour tout cas d’EIR, le contrôle du groupe sanguin, des analyses bactériologique, immunologique (test de compatibilité), sérologique et parasitaire ont été systématiquement effectués dans la poche du produit sanguin labile (PSL) et du receveur. Résultats.346 sujets ont été enrôlés (sexe féminin, 53,2%).La fréquence globale d’EIR durant la transfusion a été de 2,9%.Il s’agissait de l’urticaire (5 cas), d’un prurit (4 cas), de la fièvre (3 cas) et de vomissements (3 cas). Alors qu’en milieu alcalin, tous les tests étaient compatibles, deux cas d’incompatibilités ont été observés à la fois en milieu albumineux et de Coombs. Après contrôle de qualité des cas ayant présenté l’EIR, 5 PSL de donneurs se sont révélés positifs (HIV, 2 cas ; HVC, 2 cas et rapid plasma reagen test, RPR, 1 cas). Conclusion. L’EIR est relativement fréquente à Kinshasa due en partie par une erreur de compatibilité. L’observance des protocoles du système de l’hémovigilance n’est pas optimale dans les deux formations étudiées. Une étude multicentrique à grande échelle est à envisager pour mieux identifier les écueils de l’hémovigilance et ainsi sécuriser les PSL

    Diagnostic performance of several biomarkers for identification of cases of non-communicable diseases among Central Africans

    Get PDF
    Background: This study determined the diagnostic performance of new biomarkers for a composite diagnosis of non-communicable diseases (NCDs) among Central Africans. Methods:  This case-control study was conducted at LOMO Medical Centre, Kinshasa, DR Congo (DRC) between January – December, 2008. The cases comprised 226 participants with concurrent presence of at least 2 or more of NCDs. Anthropometric parameters and blood pressure were measured while blood samples were assayed for biomarkers. The receiver operating characteristics curve and the logistic regression model were applied.Results: Serum selenium (Se) had specificity and sensitivity of 72.4% and 91.1%, respectively with an area under the curve (AUC) of 0.802; Nitric oxide (NO) (specificity: 72.4%; sensitivity: 93.0%) (AUC = 0.800); Thyroid stimulating hormone (TSH) levels > 6 Mu/L (specificity: 75%; sensitivity: 65%) (AUC = 0.0.727); serum calcium levels of ≥ 110g/L (specificity: 76%; sensitivity: 75%) (AUC = 0.822); and daily salt intake of ≥10 g/day (specificity: 75%; sensitivity: 67%) (AUC = 0.653) in the diagnosis of all NCDs, which were all highly significant (<0.0001).  Conclusion: Serum Se, NO, calcium, TSH and daily salt intake had high diagnostic performance as biomarkers for identification of patients with concurrent NCDs in the study population. Keywords: Non-communicable diseases, diet, new biomarkers, Central Africa

    Diagnostic performance of several biomarkers for identification of cases of non-communicable diseases among Central Africans

    Get PDF
    Background: This study determined the diagnostic performance of new biomarkers for a composite diagnosis of non-communicable diseases (NCDs) among Central Africans. Methods: This case-control study was conducted at LOMO Medical Centre, Kinshasa, DR Congo (DRC) between January \u2013 December, 2008. The cases comprised 226 participants with concurrent presence of at least 2 or more of NCDs. Anthropometric parameters and blood pressure were measured while blood samples were assayed for biomarkers. The receiver operating characteristics curve and the logistic regression model were applied. Results: Serum selenium (Se) had specificity and sensitivity of 72.4% and 91.1%, respectively with an area under the curve (AUC) of 0.802; Nitric oxide (NO) (specificity: 72.4%; sensitivity: 93.0%) (AUC = 0.800); Thyroid stimulating hormone (TSH) levels > 6 Mu/L (specificity: 75%; sensitivity: 65%) (AUC = 0.0.727); serum calcium levels of 65 110g/L (specificity: 76%; sensitivity: 75%) (AUC = 0.822); and daily salt intake of 6510 g/day (specificity: 75%; sensitivity: 67%) (AUC = 0.653) in the diagnosis of all NCDs, which were all highly significant (<0.0001). Conclusion: Serum Se, NO, calcium, TSH and daily salt intake had high diagnostic performance as biomarkers for identification of patients with concurrent NCDs in the study population

    Feasibility of iFISH patterns in hematologic malignancies among Congolese patients at Kinshasa University clinics

    No full text
    Objective: To analyze the feasibility of detecting Ph1 in leukemia patients in the Kinshasa University Clinics in the Democratic Republic of Congo, at KU Leuven, Belgium. Methods: Bone marrow and peripheral blood samples with chronic myeloid leukemia, acute myeloid leukemia or acute leukocytes leukemia were obtained from 32 patients in Kinshasa University clinics in the Democratic Republic of Congo and transferred to KU Leuven in Belgium for iFISH feasibility. Ph1 was detected by using a remote analysis of interphase fluorescence in situ hybridization (iFISH). Results: Out of the 32 patients involved in this study, 65.6% (n = 21) of the cases were successfully tested, of which 52.4% (n = 11) were iFISH positives for the variant t(9;22) (presence of Ph1) in chronic myeloid leukemia samples and 47.6% (n = 10) negatives in all subtypes of hematological malignancies. However, there was a female predominance in chronic myeloid leukemia samples Ph1-positives by iFISH, whereas no sexual influence was observed on acute subtypes of leukemia. Conclusions: iFISH analysis is feasible on samples obtained from remote sites in the Democratic Republic of Congo. However, the optimization of the sample storage is necessary to further improve iFISH's performance. Keywords: iFISH, Ph1, Democratic Republic of Congo, Leukemia, Bone marrow, Bloo
    corecore